New research urges reclassifying schizophrenia as a neurodevelopmental syndrome—advancing diagnosis, care, and public ...

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead patients to struggle with making decisions and, eventually, to lose touch with reality.

Researchers have found statistically significant links between a gene tied to schizophrenia risk and poorer cognitive ...

Researchers found a grin2a mutation disrupts a brain circuit that updates beliefs using new information. In mice, restoring ...

Schizophrenia affects 1% of the global population and is caused by a complex interplay between at least 280 genes and environmental factors like childhood trauma and early cannabis use. Patients with ...

Researchers discover that a mutation in the grin2a gene impairs a thalamocortical brain circuit, preventing the brain from ...

Researchers have established an automated cage monitoring platform called IntelliCage to provide a naturalistic setting for assessing spontaneous mouse behaviors, improving preclinical models of ...

Researchers at Johns Hopkins Medicine report they have identified rare genetic variations in a protein called Thorase, which is responsible for breaking down receptors at the connections between ...

Schizotypal personality disorder and schizophrenia have numerous similarities. However, both have differences in their symptoms and diagnostic criteria. Schizotypal personality disorder (STPD) and ...